FATE THERAPEUTICS INC's ticker is FATE and the CUSIP is 31189P102. A total of 253 filers reported holding FATE THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.41 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $7,606,000 | +35.1% | 130,000 | +36.8% | 2.10% | +30.0% |
| Q3 2021 | $5,631,000 | -18.9% | 95,000 | +18.8% | 1.62% | -15.3% |
| Q2 2021 | $6,943,000 | +110.5% | 80,000 | +100.0% | 1.91% | +102.9% |
| Q1 2021 | $3,298,000 | -2.9% | 40,000 | -52.9% | 0.94% | -9.3% |
| Q3 2020 | $3,397,000 | +41.4% | 85,000 | +21.4% | 1.04% | +44.5% |
| Q2 2020 | $2,402,000 | +13.8% | 70,000 | -26.3% | 0.72% | -22.6% |
| Q1 2020 | $2,110,000 | – | 95,000 | – | 0.93% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 3,379,064 | $34,095 | 9.92% |
| Redmile Group, LLC | 12,957,222 | $130,738,370 | 5.35% |
| GCM Grosvenor Holdings, LLC | 1,037,256 | $10,465,913 | 2.67% |
| Casdin Capital, LLC | 2,050,000 | $20,684,500 | 1.60% |
| DAFNA Capital Management LLC | 550,940 | $5,558,985 | 1.57% |
| Artal Group S.A. | 2,600,000 | $26,234 | 1.46% |
| Monaco Asset Management SAM | 250,000 | $2,522,500 | 0.76% |
| Parametrica Management Ltd | 32,254 | $325,443 | 0.67% |
| Boxer Capital, LLC | 1,250,000 | $12,612,500 | 0.66% |
| Bellevue Group AG | 4,861,279 | $49,050,305 | 0.65% |